Schedule 13G ownership disclosure

GALECTO INC

Common Stock · CUSIP: 36322Q107

Event date: 2023-12-31

Filing-level shares
2,060,000.00
Percent of class
7.6%
  • Otto Erik

    Shares: 2,060,000.00 · Class: 7.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001995601-24-000002
Form type
SCHEDULE 13G/A
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Feb 09, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub